Ovarian cancer is the most deadly gynecologic malignancy, with more than 15,000 deaths
anticipated in 2012.1 While approximately 80% of patients will respond to frontline …

Conventional external-beam radiation therapy is dedicated to the treatment of localized
disease, whereas radioimmunotherapy represents an innovative tool for the treatment of …

Absorbed fractions (@) were calculated for spheres that ranged in diameter from 20@ mto
4.4 cm. The details of the computa tional procedure used have been reported elsewhere (8) …

The potential use of radionuclides in therapy has been recognized for many decades. A
number of radionuclides, such as iodine-131 (131 I), phosphorous-32 (32 P), strontium-90 …

Mucins are attracting great interest as potential targets for immunotherapy in the
development of vaccines for cancers expressing Mucinl (MUC1)(eg, breast, pancreas, ovary …

Purpose: Study distribution, pharmacokinetics, and safety of intraperitoneal (IP) 212Pb-
TCMC-trastuzumab in patients with HER-2-expressing malignancy. Experimental Design: IP …

MUC1 is a mucin family protein, overexpressed in more than 90% of breast cancers in an
underglycosylated form, exposing the core peptides of the extracellular domain that act as a …

Adult T-cell leukemia (ATL) is a malignancy of mature lymphocytes caused by the retrovirus
human T-cell lymphotropic virus-I. It is an aggressive leukemia with a median survival time of …

Purpose This was a multinational, open-label, randomized phase III trial comparing yttrium-
90–labeled murine HMFG1 (90Y-muHMFG1) plus standard treatment versus standard …

Ovarian cancer is the fifth most common cancer among females in the United States,
accounting for one fourth of all gynecologic cancers. It is the leading cause of death from …